Eli Lilly | LLY - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.96 0.93 2026-06
Abbott 23.85 1.08 2026-06
ALKERMES 135.81 96.48 2026-06
Amgen 18.07 1.77 2026-06
AstraZeneca 25.34 4.25 2026-06
Baxter International 151.95 65.95 2026-06
Biogen 23.23 9.53 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Drreddys Laboratories 19.25 0.98 2026-03
Eli Lilly 32.9 7.37 2026-06
Gilead Sciences 13.51 4.2 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
Glaxosmithkline 15.09 3.43 2026-03
J&J 29.43 4.9 2026-06
Medtronic 19.66 3.1 2026-03
Merck 32.26 15.74 2026-06
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 22.41 2.24 2026-06
Novartis 21.36 3.57 2026-03
Novo Nordisk 10.17 2.61 2026-06
Perrigo 27.45 31.51 2026-03
Pfizer 11.48 2.16 2026-06
Phibro Animal Health 13.82 4.04 2025-12
Prestige Brands 11.89 3.75 2026-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 18.96 7.12 2026-06
Sanofi 20.87 5.12 2026-03
United Therapeutics 19.15 1.27 2026-06
Zoetis 10.58 8.22 2026-06